Interpretation 345
Tier 1|
|
|
Variants
Primary Sites
Interpretation
In AML, presence of exon 17 mutations in KIT may confer an adverse prognosis or increased relapse rate. However, its significance in brain tumors is yet to be determined.
Last updated: 2017-01-20 03:37:57 UTC